Objectives The epidemiological characteristics, disease composition and cost of the respiratory system diseases from 2013 to 2017 of a third class general hospital were analyzed in order to provide the basis for taking the targeted invention measures and carrying out the evidence-based pharmaceutical research of single disease. Methods A statistical analysis was made on the cases of respiratory diseases from 2013 to 2017's hospitalized cases in a third class general hospital. The trend analysis was carried out by the linear trend test of the orderly grouping data, comparison between groups was performed using x2 test, rank sum test, Analysis of Kruskal-Wallis H test method for selecting multiple independent samples for single disease cost. Results (1) The respiratory disease was the top one disease from 2013 to 2017 in the third class general hospital, which wason the rise in 5 years(χ2value 20.457, P =0.000, <0.05). (2) The male-female ratio of hospitalized patients with respiratory diseases was 1.54:1, and males were significantly higher than females. (χ2value 12.962,P =0.011, P<0.05).(3) The top five respiratory diseases were influenza and pneumonia (50.43％), chronic lower respiratory tract infection (13.83％), respiratory system diseases (13.57％), acute upper respiratory tract infection (7.98％), and other acute lower respiratory tract infections (6.97％). (4) In single disease analysis, the basic order was chronic obstructive pulmonary disease with acute exacerbation, pneumonia, acute bronchitis, respiratory infection and acute flat head inflammation, which were based on the average hospitalization days, the average hospitalization expenses, the western medicine expenses per capita, the average drug fee per capita and the per capita check fee, Kruskal-Wallis H test, P=0.000, <0.05, the difference was statistically significant. Conclusions Respiratory diseases were common diseases and multiple disease which seriously harm people's health. The patients had large differences in gender, age distribution, and cost, and we should strengthen the importance of the disease%目的 分析某三甲综合医院2013年-2017年住院病例呼吸系统疾病流行特征、疾病构成及费用情况,为采取针对性干预措施、开展单病种的循证药学研究提供依据.方法 对该三甲综合医院2013年-2017年住院病例呼吸系统疾病病例进行统计分析,有序分组资料采用线性趋势检验进行趋势分析,组间比较采用χ2检验、秩和检验;对单病种费用选择多个独立样本的Kruskal-Wallis H 检验方法进行分析.结果 (1)呼吸系统疾病为该三甲医院2013年-2017年住院病例排列第1位的疾病,5年间呈上升趋势(χ2=20.457, P=0.000,<0.05); (2)该院呼吸系统疾病住院患者男女性别比为1.54:1,男性明显高于女性(χ2 =12.962, P=0.011,<0.05); (3)构成呼吸系统疾病的前5位依次为流行性感冒和肺炎(50.43％)、慢性下呼吸道感染(13.83％)、呼吸系统的其他疾病(13.57％)、急性上呼吸道感染(7.98％)、其他急性下呼吸道感染(6.97％);(4)单病种分析中,从平均住院日、人均住院费、人均西药费、人均中成药费、人均检查费来看,排序为慢性阻塞性肺病伴有急性加重、肺炎、急性支气管炎、呼吸道感染、急性扁头体炎,Kruskal-Wallis H 检验,P=0.000,<0.05,差异有统计学意义.结论 呼吸系统疾病是严重危害人们健康的常见病、多发病,其患者在性别、年龄别分布、费用情况等均有较大差异,应加强对该疾病的重视.
展开▼
